Officials Visit Shenzhen True Flavor Biotech for Industry Research

Aug.08.2022
Officials Visit Shenzhen True Flavor Biotech for Industry Research
Shenzhen officials visit Shenzhen Zhenwei Bioscience to discuss their development plans and commend their innovative progress.

On August 4th, a delegation led by Cai Ying, Secretary of the Guangming District Committee in Shenzhen, including Shen Huaxin and Zhang Feng, both members of the District Committee, visited Shenzhen Truly Bio-Tech Co., Ltd. They were accompanied by Peng Hua, Deputy Director of the District Committee and Government Office, Lin Shuping, Director of the District Industrial and Information Bureau, Liu Kun, Secretary of the Yutang Street Party Working Committee, Liu Li, Deputy Director of the District Investment Promotion Service Center, and Zeng Peisheng, Deputy Director of the Guangming District Tobacco Monopoly Bureau. The general manager of Truly Bio-Tech, Zou Yang, and other members of management welcomed and hosted the delegation.


A research team conducted a site visit to the offices of Truly Flavored Biotech and received a detailed explanation from the company's leader on various aspects of the company's functional centers, including the introduction of top research equipment, the standardization of process systems, the improvement of talent, and the upgrading of industry intelligence. The team also observed the operation of the Aerosol Technology Research Institute, the pharmaceutical-grade GMP cleanroom, the quality control center, and the fragrance development center, gaining a thorough understanding of the current state of technology personnel, hardware and software facilities, and product development progress. The team engaged in in-depth discussions with staff members and gained a comprehensive understanding of the processes involved in raw material selection, quality testing, and new product research and development. The team fully recognized Truly Flavored Biotech's efforts to "promote innovation-led industry and drive development with scientific research" as a benchmark, a growth booster, and a long-term strategy.


After the visit, a symposium was held under the chairmanship of the Huanxin Executive Committee of the research group.


During the symposium, Secretary Cai Ying fully recognized the work of Zhenwei Biology. She pointed out that as a leading company in the electronic atomized liquid industry, Zhenwei Biology not only has a strong development momentum, but also actively undertakes corporate social responsibility. The company is also forward-thinking in research and innovation, market judgment, and new enterprise layout. At the same time, Secretary Cai Ying expressed deep concern for the company's future development plan. She hopes that Zhenwei Biology will further improve its industrial layout, seize opportunities for further development and expansion, and integrate into the overall development of the Guangming Science City. Meanwhile, the government and various departments of Guangming District will continue to implement pro-enterprise and supportive policies, providing top-notch services and quality space for long-term development and stability of enterprises. The government aims to maintain the vitality of the market, job security, and the welfare of the people in promoting the steady and progressive development of the local economy.


During the meeting, the research team listened to a report from Mr. Zou Yang, the General Manager of Zhenwei Biotech, on the progress and achievements of the company's phase work and the strategic planning for future development. Mr. Zou focused on the current national policies for the electronic atomized liquid industry, Zhenwei's development of new products in compliance with national standards, and the company's economic growth in the first half of the year. He stated that with the help of preferential policies from the government and various departments in Guangming District, Zhenwei Biotech's economic growth has been rapidly increasing since the first half of 2022. Furthermore, in order to better implement industry policy requirements, Zhenwei Biotech established the Zhenwei Biotech (Yunnan) Research Institute immediately after obtaining the tobacco monopoly production license, and is fully engaged in the research of tobacco-flavored atomized products. Zhenwei Biotech hopes to cooperate with the industry's upstream and downstream industries to create electronic atomized products with international influence.


The General Manager, Zou Yang, also stated that Zhenwei Biology will establish itself in Guangming, adhere to the real economy, persist in innovation, elevate its standards, strive to improve the company's efficiency and size, and firmly uphold the industry mission of "being a role model, setting an example, and leading the way." With a foundation in the electronic atomization liquid industry, they will develop in multiple modes, channels, and diversify cooperation, continuously improve market confidence with new development and achievements, make greater contributions to socio-economic development, and also hope that Zhenwei Biology will rely on its strong scientific research capabilities to make a positive contribution to the economic development of Guangming district.


The visit by district leaders is a strong recognition of the achievements in our company's development. In the future, Zhenwei Biological will proactively embrace regulation, adhere to industry policy requirements and government calls, increase research and development investment, and persist in pursuing high-quality development. We will contribute to the economic development of Guangming District and create a win-win outcome.


This article contains excerpts or reprints from third-party sources whose copyrights belong to the original media and authors. If there is any infringement, please contact us for deletion. Any individual or organization that wants to reprint this content should contact the author and refrain from direct reposting.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Alabama Senate Passes SB9 to Ban Vaping in Indoor Public Places
Alabama Senate Passes SB9 to Ban Vaping in Indoor Public Places
Alabama’s Senate approved SB9 by a 31–1 vote, expanding existing indoor smoking restrictions to include vaping in a wide range of public places. The bill keeps the current $25 fine, renames the state’s Clean Indoor Air Act, and now heads to the House. If enacted, it would take effect on Oct. 1, 2026.
Feb.02 by 2FIRSTS.ai
Around 58,000 counterfeit vapes and tobacco seized from UK 's Hampshire streets over the past year
Around 58,000 counterfeit vapes and tobacco seized from UK 's Hampshire streets over the past year
UK's Hampshire Trading Standards says around 58,000 counterfeit vapes and tobacco products have been seized from Hampshire over the last year. Richard Strawson, Hampshire’s Head of Trading Standards, said officers often find vape products disguised under fake branding.
Jan.05 by 2FIRSTS.ai
Russia’s Volgograd Police Seize Illicit Nicotine Products Worth Over US$42.9K+
Russia’s Volgograd Police Seize Illicit Nicotine Products Worth Over US$42.9K+
Police in Russia’s Volgograd region say they seized nicotine products lacking mandatory markings valued at more than RUB 3.3 million (about US$42,900+, using RUB 1 = US$0.013). A 43-year-old suspect allegedly stored and sold the products through two retail outlets in Volgograd’s Central and Dzerzhinsky districts. A criminal case has been opened under Article 171.1(6) of the Russian Criminal Code.
Jan.30 by 2FIRSTS.ai
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11
Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads
Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads
The Kansas Senate approved Senate Bill 355 on Wednesday, aiming to crack down on unlicensed vaping products and eliminate advertisements geared toward children. The bill, backed by major tobacco companies, would impose the same licensing and advertising requirements on e-cigarettes as other nicotine products and require every e-cigarette manufacturer doing business in Kansas to obtain a license, with a $2,500 application fee.
Feb.13 by 2FIRSTS.ai
22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap
22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap
22nd Century Group (Nasdaq: XXII) reported early commercial momentum for its FDA-authorized VLN® very low nicotine cigarettes, distributing approximately 8,800 cartons across 1,700 new U.S. retail outlets in the fourth quarter of 2025, while forecasting expansion to more than 5,000 retail points in 2026.
Business
Feb.24